Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0002 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |